Human CRC cell line SW620 was purchased from the American Tissue Culture Collection (Manassas, VA, USA). Human CRC cell lines HCT116 and SW480 were purchased from DS Pharmabiomedical (Osaka, Japan). L-OHP-resistant SW620 (SW620-OxR) cells were prepared as previously reported [9 (link)]. SW620, SW620-OxR, and SW480 cells were grown in Leibovitz's L-15 medium (Life Technologies Corp., Carlsbad, CA, USA) plus 10% fetal bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C in 100% air. SW620-OxR cells were grown with 80 μM L-OHP (Tokyo Chemical Industry Co., Tokyo, Japan) and were cultured without L-OHP for 1 passage before experiments. HCT116 cells were grown in McCoy's 5A medium (Life Technologies Corp.) plus 10% FBS, 100 U/mL penicillin, and 100 μg/mL streptomycin at 37 °C in 5% CO2 air.
+ Open protocol